Patents by Inventor Jessica Preciado
Jessica Preciado has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220280218Abstract: The present invention generally relates to improved medical devices, systems, and methods. In many embodiments, devices, systems, and methods for locating and treating a target nerve with cold therapy are provided. For example, a focused cold therapy treatment device may be provided that is adapted to couple with or be fully integrated with a nerve stimulation device such that nerve stimulation and focused cold therapy may be performed concurrently with the cryo-stimulation device. Improvements in nerve localization and targeting may increase treatment accuracy and physician confidence in needle placement during treatment. In turn, such improvements may decrease overall treatment times, the number of repeat treatments, and the re-treatment rate. Further, additional improvements in nerve localization and targeting may reduce the number of applied treatment cycles and may also reduce the number of cartridge changes (when replaceable refrigerant cartridges are used).Type: ApplicationFiled: March 21, 2022Publication date: September 8, 2022Applicant: Pacira CryoTech, Inc.Inventors: Ann S. Lee, Matt Antonelli, Badier Velji, Jessica Preciado Dummett
-
Publication number: 20220151673Abstract: In some embodiments, a method includes identifying a nerve extending across a transection path; administering a cooling therapy to the identified nerve at a location proximal to the transection path so as to degenerate the identified nerve across the transection path prior to or during surgical transection along the transection path, wherein cooling the identified nerve prevents or reduces neuroma formation at a transected end of the nerve after transection of the nerve. In some embodiments, a method includes degenerating a portion of a nerve while preserving a connective tissue framework of the nerve. During or after the degeneration, the preserved connective tissue framework may be transected at a transection location distal to the treatment location. The regeneration of the nerve may be repeatedly disrupted for a period of time to reduce a regenerative rate of the nerve and delay neuroma formation.Type: ApplicationFiled: February 2, 2022Publication date: May 19, 2022Applicant: Pacira CryoTech, Inc.Inventors: John Allison, Jessica Preciado Dummett, Michael Hsu
-
Patent number: 11311327Abstract: The present invention generally relates to improved medical devices, systems, and methods. In many embodiments, devices, systems, and methods for locating and treating a target nerve with cold therapy are provided. For example, a focused cold therapy treatment device may be provided that is adapted to couple with or be fully integrated with a nerve stimulation device such that nerve stimulation and focused cold therapy may be performed concurrently with the cryo-stimulation device. Improvements in nerve localization and targeting may increase treatment accuracy and physician confidence in needle placement during treatment. In turn, such improvements may decrease overall treatment times, the number of repeat treatments, and the re-treatment rate. Further, additional improvements in nerve localization and targeting may reduce the number of applied treatment cycles and may also reduce the number of cartridge changes (when replaceable refrigerant cartridges are used).Type: GrantFiled: May 12, 2017Date of Patent: April 26, 2022Assignee: Pacira CryoTech, Inc.Inventors: Ann S. Lee, Matt Antonelli, Badier Velji, Jessica Preciado Dummett
-
Patent number: 11272972Abstract: In some embodiments, a method includes identifying a nerve extending across a transection path; administering a cooling therapy to the identified nerve at a location proximal to the transection path so as to degenerate the identified nerve across the transection path prior to or during surgical transection along the transection path, wherein cooling the identified nerve prevents or reduces neuroma formation at a transected end of the nerve after transection of the nerve. In some embodiments, a method includes degenerating a portion of a nerve while preserving a connective tissue framework of the nerve. During or after the degeneration, the preserved connective tissue framework may be transected at a transection location distal to the treatment location. The regeneration of the nerve may be repeatedly disrupted for a period of time to reduce a regenerative rate of the nerve and delay neuroma formation.Type: GrantFiled: October 3, 2019Date of Patent: March 15, 2022Assignee: Pacira CryoTech, Inc.Inventors: John Allison, Jessica Preciado Dummett, Michael Hsu
-
Publication number: 20210393309Abstract: The present invention generally relates to improved medical devices, systems, and methods. In many embodiments, devices, systems, and methods for locating and treating a target nerve with integrated cold therapy and electrical stimulation systems are provided. For example, nerve stimulation and cryoneurolysis may be delivered concurrently or alternately with the cryo-stimulation device. In some embodiments, the device may be operated by a single operator or clinician. Accordingly, embodiments of the present disclosure may improve nerve targeting during cryoneurolysis procedures. Improvements in nerve localization and targeting may increase treatment accuracy, physician confidence in needle placement during treatment, and clinical efficacy and safety. In turn, such improvements may decrease overall treatment times, the number of repeat treatments, and the re-treatment rate.Type: ApplicationFiled: September 1, 2021Publication date: December 23, 2021Applicant: Pacira CryoTech, Inc. (025917)Inventors: Ann Lee Cross, Erika Danielle Anderson-Bolden, Jessica Preciado Dummett, Eric Theodore Johansson, Paul Tanaka-Roche
-
Patent number: 11134998Abstract: The present invention generally relates to improved medical devices, systems, and methods. In many embodiments, devices, systems, and methods for locating and treating a target nerve with integrated cold therapy and electrical stimulation systems are provided. For example, nerve stimulation and cryoneurolysis may be delivered concurrently or alternately with the cryo-stimulation device. In some embodiments, the device may be operated by a single operator or clinician. Accordingly, embodiments of the present disclosure may improve nerve targeting during cryoneurolysis procedures. Improvements in nerve localization and targeting may increase treatment accuracy, physician confidence in needle placement during treatment, and clinical efficacy and safety. In turn, such improvements may decrease overall treatment times, the number of repeat treatments, and the re-treatment rate.Type: GrantFiled: November 15, 2018Date of Patent: October 5, 2021Assignee: Pacira CryoTech, Inc.Inventors: Ann Lee Cross, Erika Danielle Anderson-Bolden, Jessica Preciado Dummett, Eric Theodore Johansson, Paul Tanaka-Roche
-
CRYOPROTECTANT FOR USE WITH A TREATMENT DEVICE FOR IMPROVED COOLING OF SUBCUTANEOUS LIPID-RICH CELLS
Publication number: 20200155215Abstract: A cryoprotectant for use with a treatment device for improved removal of heat from subcutaneous lipid-rich cells of a subject having skin is provided. The cryoprotectant is a non-freezing liquid, gel, or paste for allowing pre-cooling of the treatment device below 0° C. while preventing the formation of ice thereon. The cryoprotectant may also prevent freezing of the treatment device to the skin or ice from forming from moisture seeping out from the skin. The cryoprotectant may further be hygroscopic, thermally conductive, and biocompatible.Type: ApplicationFiled: October 8, 2019Publication date: May 21, 2020Inventors: Mitchell E. Levinson, Donald Johnson, Jessica Preciado, Edward A. Ebbers, Daniel Bucks -
Publication number: 20200030016Abstract: In some embodiments, a method includes identifying a nerve extending across a transection path; administering a cooling therapy to the identified nerve at a location proximal to the transection path so as to degenerate the identified nerve across the transection path prior to or during surgical transection along the transection path, wherein cooling the identified nerve prevents or reduces neuroma formation at a transected end of the nerve after transection of the nerve. In some embodiments, a method includes degenerating a portion of a nerve while preserving a connective tissue framework of the nerve. During or after the degeneration, the preserved connective tissue framework may be transected at a transection location distal to the treatment location. The regeneration of the nerve may be repeatedly disrupted for a period of time to reduce a regenerative rate of the nerve and delay neuroma formation.Type: ApplicationFiled: October 3, 2019Publication date: January 30, 2020Applicant: Pacira CryoTech, Inc.Inventors: John Allison, Jessica Preciado Dummett, Michael Hsu
-
Patent number: 10470813Abstract: The present invention generally relates to improved medical devices, systems, and methods. In many embodiments, devices, systems, and methods for amputating a limb of a patient are provided. In many embodiments, devices, systems, and methods may provide chronic denervation of one or more nerves of a patient as part of a therapeutic treatment. The methods may employ cold for the prevention of neuromas or fibromas associated with amputation of a limb of a patient. Embodiments of the invention include needles that can be advanced through skin or other tissues to cause axonotmesis of a target nerve of the patient and to repeatedly interrupt a regeneration of the nerve so as to provide therapeutic chronic denervation of the target nerve. The therapeutic chronic denervation may delay the formation of neuromas or fibromas in a patient's residual limb and/or may provide long lasting and permanent pain relief associated with the target nerve.Type: GrantFiled: March 14, 2016Date of Patent: November 12, 2019Assignee: Pacira CryoTech, Inc.Inventors: John Allison, Jessica Preciado Dummett, Michael Hsu
-
Publication number: 20190142494Abstract: The present invention generally relates to improved medical devices, systems, and methods. In many embodiments, devices, systems, and methods for locating and treating a target nerve with integrated cold therapy and electrical stimulation systems are provided. For example, nerve stimulation and cryoneurolysis may be delivered concurrently or alternately with the cryo-stimulation device. In some embodiments, the device may be operated by a single operator or clinician. Accordingly, embodiments of the present disclosure may improve nerve targeting during cryoneurolysis procedures. Improvements in nerve localization and targeting may increase treatment accuracy, physician confidence in needle placement during treatment, and clinical efficacy and safety. In turn, such improvements may decrease overall treatment times, the number of repeat treatments, and the re-treatment rate.Type: ApplicationFiled: November 15, 2018Publication date: May 16, 2019Inventors: Ann Lee Cross, Erika Danielle Anderson-Bolden, Jessica Preciado Dummett, Eric Theodore Johansson, Paul Tanaka-Roche
-
Publication number: 20180116705Abstract: The present invention generally relates to improved medical devices, systems, and methods. In many embodiments, devices, systems, and methods for locating and treating a target nerve with cold therapy are provided. For example, a focused cold therapy treatment device may be provided that is adapted to couple with or be fully integrated with a nerve stimulation device such that nerve stimulation and focused cold therapy may be performed concurrently with the cryo-stimulation device. Improvements in nerve localization and targeting may increase treatment accuracy and physician confidence in needle placement during treatment. In turn, such improvements may decrease overall treatment times, the number of repeat treatments, and the re-treatment rate. Further, additional improvements in nerve localization and targeting may reduce the number of applied treatment cycles and may also reduce the number of cartridge changes (when replaceable refrigerant cartridges are used).Type: ApplicationFiled: May 12, 2017Publication date: May 3, 2018Inventors: Ann S. Lee, Matt Antonelli, Badier Velji, Jessica Preciado Dummett
-
Publication number: 20160262820Abstract: The present invention generally relates to improved medical devices, systems, and methods. In many embodiments, devices, systems, and methods for amputating a limb of a patient are provided. In many embodiments, devices, systems, and methods may provide chronic denervation of one or more nerves of a patient as part of a therapeutic treatment. The methods may employ cold for the prevention of neuromas or fibromas associated with amputation of a limb of a patient. Embodiments of the invention include needles that can be advanced through skin or other tissues to cause axonotmesis of a target nerve of the patient and to repeatedly interrupt a regeneration of the nerve so as to provide therapeutic chronic denervation of the target nerve. The therapeutic chronic denervation may delay the formation of neuromas or fibromas in a patient's residual limb and/or may provide long lasting and permanent pain relief associated with the target nerve.Type: ApplicationFiled: March 14, 2016Publication date: September 15, 2016Inventors: John Allison, Jessica Preciado Dummett, Michael Hsu
-
CRYOPROTECTANT FOR USE WITH A TREATMENT DEVICE FOR IMPROVED COOLING OF SUBCUTANEOUS LIPID-RICH CELLS
Publication number: 20140005760Abstract: A cryoprotectant for use with a treatment device for improved removal of heat from subcutaneous lipid-rich cells of a subject having skin is provided. The cryoprotectant is a non-freezing liquid, gel, or paste for allowing pre-cooling of the treatment device below 0° C. while preventing the formation of ice thereon. The cryoprotectant may also prevent freezing of the treatment device to the skin or ice from forming from moisture seeping out from the skin. The cryoprotectant may further be hygroscopic, thermally conductive, and biocompatible.Type: ApplicationFiled: January 22, 2013Publication date: January 2, 2014Applicant: ZELTIQ AESTHETICS, INC.Inventors: Mitchell E. Levinson, Donald Johnson, Jessica Preciado, Edward A. Ebbers, Daniel Bucks -
Publication number: 20090118722Abstract: A system for reducing subcutaneous lipid-rich cells or tissue of a subject is disclosed. The system may include a fluid supply, a probe in fluid communication with the fluid supply, and a coolant circulated between the fluid supply and the probe. The probe may be configured to be inserted into the subject to be at least proximate to the subcutaneous lipid rich cells. The coolant may be at a temperature such that the subcutaneous lipid-rich cells or tissue proximate to the inserted probe are cooled.Type: ApplicationFiled: October 31, 2007Publication date: May 7, 2009Inventors: Edward A. Ebbers, Mitchell E. Levinson, Jessica Preciado, Nathan R. Every, John W. Allison
-
Publication number: 20070255362Abstract: A cryoprotectant for use with a treatment device for improved removal of heat from subcutaneous lipid-rich cells of a subject having skin is provided. The cryoprotectant is a non-freezing liquid, gel, or paste for allowing pre-cooling of the treatment device below 0° C. while preventing the formation of ice thereon. The cryoprotectant may also prevent freezing of the treatment device to the skin or ice from forming from moisture seeping out from the skin. The cryoprotectant may further be hygroscopic, thermally conductive, and biocompatible.Type: ApplicationFiled: April 27, 2007Publication date: November 1, 2007Applicant: Juniper Medical, Inc.Inventors: Mitchell E. Levinson, Donald Johnson, Jessica Preciado, Edward A. Ebbers, Daniel Bucks